Born Ready: Innovations for Every Preemie, Everywhere

Challenge details

What is this challenge?

Our mission is to support projects and ideas that:

  • Prioritize patient needs
  • Contribute to sustainable healthcare practices
  • Reduce health inequity
  • Create value for society

From a technological point of view, we will prioritize innovative and sustainable solutions in the field of MEDTECH, DIAGNOSTICS and DIGITAL, but we are open to evaluate also pharmaceutical or therapeutic solutions that are rule-breakers.

Full availability of eventual IP or know-how by the proposer is required.

Important Note: Neonatal Intensive Care Unit (NICU), with a strong emphasis on non-invasive monitoring is the preferred environment (Hospital Setting), but we will also evaluate solutions that can support parents or caregivers after the de-hospitalization of the baby as innovations for baby monitoring to improve diseases management in all settings and reduce rehospitalization and infection risks.

We are also seeking solutions that will improve the availability and access to medicine and cures for babies in low-income countries.

 

What we offer:

We believe that great ideas can come from anywhere, and we are committed to providing the support, guidance, and partnership opportunities that innovators need to turn their visions into reality.

  • Partnership Opportunities - We will collaborate on projects that have the potential to change healthcare for the better.
  • Support & Resources - We offer access to support opportunities for research & development and the tools needed to bring your ideas to life.
  • Mentorship & Guidance - Our team of seasoned professionals is here to provide strategic advice, help navigate regulatory challenges, and ensure your project stays on track.
  • Global Network - Tap into Chiesi's global network of partners and stakeholders, gaining exposure and support from key players in the healthcare industry.

We leverage collaboration beyond company boundaries to foster growth. Good ideas can come from anywhere, and we welcome diverse perspectives. 

Our innovations are guided by a commitment to environmental, social, and economic sustainability, ensuring that the future we build is prosperous and accessible.

We synergize with internal Business Units, functions, and external partners, co-creating solutions that benefit both Chiesi and the wider ecosystem.

We embrace digital technologies to create new solutions and improve processes for a more efficient and innovative healthcare landscape.

INNOVATIVE PoCs and a series of activities envisioned to demonstrate the potential effectiveness and value of an early-stage project, change business idea or product/service idea and help validate the potential success of a project, particularly in cases where what is being attempted is new or novel, such as the creation of new products, technologies, and services, or changing processes.
HOW: identify a unique problem and brainstorm potential solutions, also by developing a prototype to demonstrate the feasibility of the solution. 

VENTURE CLIENTING: to engage with startups as clients leveraging startup agility and creativity and to gain immediate access to innovation driven by startups by directly purchasing solutions that meet or will meet their business needs. 
 

Timeline

Sep. 24

Applications Open

Nov. 30

Applications Close

Q1 2026

Partnerships with Chiesi & Network

Neonatal Respiratory Distress Syndrome (NRDS) & Apnea of Prematurity (AOP)
Bronchopulmonary Dysplasia (BPD)
Intestinal Malabsorption (IM)
Hypoxic Ischaemic Encephalopathy (HIE)

Applications for this challenge have closed.

For more information about our programs and challenges
View all ->

Benefits for Applicants

Partnership Opportunities

We co-develop projects with the potential to reshape healthcare, leveraging shared expertise and mutual goals.

Support & Resources

Innovators gain access to research and development support, tools, and infrastructure to accelerate their solutions.

Mentorship & Guidance

Our experienced professionals offer strategic advice, regulatory insights, and project navigation to keep ideas on track.

Global Network

Tap into Chiesi’s international ecosystem of partners and stakeholders to amplify your impact.

Sustainability Commitment

Every innovation is guided by our dedication to environmental, social, and economic sustainability.

Digital Transformation

We embrace digital technologies to enhance healthcare delivery and operational efficiency.

Collaborative Culture

We foster open innovation across internal teams and external collaborators, welcoming diverse perspectives and co-creating value.

Proof of Concept Pathways

We support early-stage projects through PoCs that validate feasibility, value, & scalability; such as novel products, services or processes.

Venture Clienting

We engage with startups as clients, directly adopting solutions that meet real business needs and accelerating their market entry.

Innovation Focus Areas

PREVENTION, PREDICTION AND EARLY IDENTIFICATION

  •  • Prevent/Predict comorbidities of pre-term babies (e.g., BPD/CLD, EoP, NEC, ROP, infections, etc) soon after birth.

IMPROVED DISEASE MANAGEMENT, MONITORING AND TREATMENT ADHERENCE ALSO AFTER NICU DISCHARGE

  •  • Non-invasive monitoring (NICU)
  •  • Smart, sustainable and less invasive drug delivery & neonatal care solutions, to be primarily applied to Chiesi portfolio and pipeline products.
  •  • Digital health innovations (apps for baby monitoring).
  •  • Improve nRDS management (e.g.provide respiratory rehabilitation, digital health solution)
  •  • Reduce rehospitalization and infection risks.
  •  • Strengthen parent-child bonding and provide psychological support.
  •  • Educate parents on home care (vaccines, infection prevention, oxygen portability).
  •  • Improve clinical trial experiences (decentralized tele-visits, remote monitoring).

INNOVATIVE BIOTECHNOLOGICAL APPROACHES

  •  • Innovative treatment approach concerning Neonatal Respiratory Distress Syndrome (NRDS) and Bronchopulmonary Dysplasia, (BPD) (both in high priority), Intestinal Malabsorption (IM), and Hypoxic Ischemic Encephalopathy (HIE).  Ex. Cell and Gene Therapies, Molecular and Protein Therapeutics, Tissue Engineering and Biomaterials, New drug modalities: i.e. Extraeellular vesicles, Live biotherapeutic products, Advanced targeted Drug Delivery Systems and Disease Modeling and Screening Platforms.

EXPANDED ACCESS FOR HEALTH EQUITY PURPOSE

  •  • Reduce health inequalities and barriers to treatment through affordable, durable solutions to support parents with managing complications after treatment adaptable to low-resource settings/less developed countries to bridge healthcare disparities.

  •  • Expanded neonatal care access, especially in low-resource settings.

  •  • Enhancing existing initiatives or launching new ones

The Impulse by Chiesi

 

Applications are now closed.

Applications for this challenge have closed.

For more information about our programs and challenges
View all ->